Drug Discovery Opinion

The bacterium responsible for tuberculosis (TB), mycobacterium tuberculosis (Mtb), is notoriously difficult to kill. The most commonly used antibiotics, rifampicin and isoniazid, need to be used for extended periods of time (typically 6-24 months) to effectively eliminate infection. In addition, emergence of antibiotic-resistant strains is an increasing problem.

Researchers at Albert Einstein College of Medicine of Yeshiva University have now identified a new biochemical pathway in Mtb and two novel ways to kill the bacterium. The pathway involves four enzymatic steps in the conversion of the disaccharide, trehalose, to α-glucan mediated by TreS, Pep2, GlgE (which has been identified as a maltosyltransferase that uses maltose 1-phosphate) and GlgB. Focusing on GlgE, the researchers found that blocking the enzyme induced toxic accumulation of maltose-1-phosphate, killing the bacteria in vitro and in a mouse model of infection. Inhibition of another enzyme in the pathway was non-lethal until combined with inactivation of Rv3032, a glucosyltransferase involved in a distinct α-glucan pathway. Inhibition of Rv3032 alone was also non-lethal to the bacteria.

The research validates inhibition of GlgE as therapy for TB but also highlights the potential for targeting two α-glucan pathways – a strategy that potentially leads to reduced incidence of resistance. Both approaches are also distinct from the mechanisms of currently used antibiotics.

The study is published in Nature Chemical Biology.

Related posts:

1. mTOR Linked to Myelin Repair The axons of nerve cells are sheathed by an insulating layer of myelin which is made up of about 80%...
2. Human Haploid Cell Line Identifies Potential Drug Targets The identification of host genes that are exploited by bacteria and viruses could lead to new therapeutic targets but gene...
3. Stomach Bugs Need Vitamin B6 Approximately half of the world’s population is infected with Helicobacter pylori, the bacterium that causes peptic ulcers and some forms...
4. NSAIDs and Cancer – Another Piece of the Puzzle Regular use of NSAIDS has been linked to reduced incidence of certain types of cancer but the underlying protective mechanisms...
5. Kinase Target for Toxoplasmosis, maybe Malaria Apicomplexan parasites such as Toxoplasma gondii and Plasmodium species can cause serious diseases in humans and domestic animals. Because the...

Related posts brought to you by Yet Another Related Posts Plugin.

 Email This Post

This entry was posted on Monday, March 22nd, 2010 at 11:24 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.